Pharmaceutical Executive-05-01-2008

Special Reports
Pharmaceutical Executive

May 01, 2008

Your guide to the world's top 50 pharma companies. The giants may be struggling, but even in a tough year, the industry's most successful companies know how to hit the bullseye.

Pharmaceutical Executive
Features

May 01, 2008

In these cost cutting times, no drugmaker can afford to keep shoveling money down the Rebate Black Hole. Here's how to optimize your ROI and push back against the growing pressure of third-party rebates

Pharmaceutical Executive

Pharmacoactuarial analysis helps drug companies communicate value to health plans

Pharmaceutical Executive

Tracking business by indication is critical for evaluating market performance and making accurate resource allocations

Pharmaceutical Executive
Opinion

May 01, 2008

Pharma can stand to win hearts, minds, and tax credits by launching an eco bandwagon

Pharmaceutical Executive
Commentary

May 01, 2008

More patients are demanding drugs--and showing up everywhere form YouTube to the Supreme Court. But to offer access to investigational drugs, companies first need to know the rules

Pharmaceutical Executive
Features

May 01, 2008

How do you find and license the best drugs out there? If you're Merck, you send scientists to go get 'em

Pharmaceutical Executive
Columns

May 01, 2008

Technology isn't the magic bullet, but it can help you hit your target

Pharmaceutical Executive

Your current backup and recovery strategy may be leaving you vulnerable to non-compliance, significant revenue loss, and negative brand exposure. Learn how to protect your business

Pharmaceutical Executive
Columns

May 01, 2008

The tech-savvy creative team at Concentric Rx has its sales force mixing work and play

Pharmaceutical Executive
Columns

May 01, 2008

Thanks to Dr. Google and Nurse Yahoo, pharma consumers know better than ever how to get exactly what they want

Pharmaceutical Executive
Features

May 01, 2008

Promotional spending is down as companies rationalize and optimize budgets. But in contrast to big changes on the sales side, marketers are still trying to make the old model work

Pharmaceutical Executive
Features

May 01, 2008

Meet the Korean pharma consumer: affluent, aging, and crazy about drugs

Pharmaceutical Executive
Features

May 01, 2008

One company's program provides an interesting model for the future of DTP

Pharmaceutical Executive

How to stretch that portfolio to make ends meet

Pharmaceutical Executive
Features

May 01, 2008

San Diego's booming biotech cluster searches for its future-and yours

Pharmaceutical Executive
Washington Report

May 01, 2008

FDA is being pressured to get its act together. The agency says it needs more money and more people to get approvals out the door

Pharmaceutical Executive

A plunging currency and other economic turmoil shouldn't phase pharma, right? Yes and no